Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 224

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway

Bento, Allisson Freire, Marcon, Rodrigo, Dutra, Rafael Cypriano, Claudino, Rafaela Franco, Cola, Maíra, Pereira Leite, Daniela Ferraz, Calixto, João B.·2011·The American Journal of Pathology
DOI 10.1016/j.ajpath.2010.11.052
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2010.11.052

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 66

  1. Cuzzocrea, 2003, Emerging biotherapies for inflammatory bowel disease, Expert Opin Emerg Drugs, 8, 339, 10.1517/14728214.8.2.339 · DOI
  2. Podolsky, 2002, The current future understanding of inflammatory bowel disease, Best Pract Res Clin Gastroenterol, 16, 933, 10.1053/bega.2002.0354 · DOI
  3. McGuckin, 2009, Intestinal barrier dysfunction in inflammatory bowel diseases, Inflamm Bowel Dis, 15, 100, 10.1002/ibd.20539 · DOI · Paper page
  4. Roberds, 2001, BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics, Hum Mol Genet, 10, 1317, 10.1093/hmg/10.12.1317 · DOI · Paper page
  5. D'Argenio, 2006, Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation, FASEB J, 20, 568, 10.1096/fj.05-4943fje · DOI
  6. Galiègue, 1995, Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur J Biochem, 232, 54, 10.1111/j.1432-1033.1995.tb20780.x · DOI · Paper page
  7. Maresz, 2007, Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells, Nat Med, 13, 492, 10.1038/nm1561 · DOI
  8. Bento, 2008, The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice, J Leukoc Biol, 84, 1213, 10.1189/jlb.0408231 · DOI
  9. Kühl, 2007, Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils, Gastroenterology, 133, 1882, 10.1053/j.gastro.2007.08.073 · DOI · Paper page
  10. Morgan, 2009, Functional CB2 type cannabinoid receptors at CNS synapses, Neuropharmacology, 57, 356, 10.1016/j.neuropharm.2009.07.017 · DOI
  11. O'Sullivan, 2005, Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma, Biochem Biophys Res Commun, 337, 824, 10.1016/j.bbrc.2005.09.121 · DOI
  12. Rousseaux, 2005, Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma, J Exp Med, 201, 1205, 10.1084/jem.20041948 · DOI
  13. Schaefer, 2005, Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms, Inflamm Bowel Dis, 11, 244, 10.1097/01.MIB.0000160770.94199.9b · DOI
  14. Jiang, 1998, PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/34184 · DOI · Paper page
  15. Wahli, 2008, A gut feeling of the PXR, PPAR and NF-kappaB connection, J Intern Med, 263, 613, 10.1111/j.1365-2796.2008.01951.x · DOI
  16. Dubuquoy, 2003, Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis, Gastroenterology, 124, 1265, 10.1016/S0016-5085(03)00271-3 · DOI
  17. Lefebvre, 1999, Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells, J Endocrinol, 162, 331, 10.1677/joe.0.1620331 · DOI
  18. Buisine, 2001, Mucin gene expression in intestinal epithelial cells in Crohn's disease, Gut, 49, 544, 10.1136/gut.49.4.544 · DOI · Paper page
  19. Gertsch, 2008, Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action?, Commun Integr Biol, 1, 26, 10.4161/cib.1.1.6568 · DOI
  20. Orav, 2004, Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states, J Agric Food Chem, 52, 2582, 10.1021/jf030635s · DOI
  21. de Carvalho, 2004, Chemical composition and antimicrobial activity of the essential oil of Cordia verbenacea D.C, J Ethnopharmacol, 95, 297, 10.1016/j.jep.2004.07.028 · DOI
  22. Vandenbark, 1996, Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial [Erratum appeared in Nat Med 1997;3:240], Nat Med, 2, 1109, 10.1038/nm1096-1109 · DOI
  23. Kimball, 2004, Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice, Neurogastroenterol Motil, 16, 811, 10.1111/j.1365-2982.2004.00549.x · DOI
  24. Storr, 2009, Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis, Inflamm Bowel Dis, 15, 1678, 10.1002/ibd.20960 · DOI
  25. Napimoga, 2008, Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway, J Immunol, 180, 609, 10.4049/jimmunol.180.1.609 · DOI
  26. Rogerio, 2009, Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation, Br J Pharmacol, 158, 1074, 10.1111/j.1476-5381.2009.00177.x · DOI
  27. Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
  28. Stanley, 1997, Murine bone marrow-derived macrophages, Methods Mol Biol, 75, 301
  29. Vitor, 2009, Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis, Br J Pharmacol, 157, 1034, 10.1111/j.1476-5381.2009.00271.x · DOI
  30. Baumgart, 2007, Inflammatory bowel disease: cause and immunobiology, Lancet, 369, 1627, 10.1016/S0140-6736(07)60750-8 · DOI · Paper page
  31. Barker, 1991, Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma, J Immunol, 146, 1192, 10.4049/jimmunol.146.4.1192 · DOI
  32. Arulampalam, 2002, Uncoupling the p38 MAPK kinase in IBD: a double edged sword?, Gut, 50, 446, 10.1136/gut.50.4.446 · DOI
  33. Harrington, 2008, Construction and analysis of a modular model of caspase activation in apoptosis, Theor Biol Med Model, 5, 26, 10.1186/1742-4682-5-26 · DOI
  34. Tsukita, 2000, The structure and function of claudins, cell adhesion molecules at tight junctions, Ann N Y Acad Sci, 915, 129, 10.1111/j.1749-6632.2000.tb05235.x · DOI
  35. Massa, 2004, The endogenous cannabinoid system protects against colonic inflammation, J Clin Invest, 113, 1202, 10.1172/JCI200419465 · DOI
  36. Burstein, 2005, PPAR-gamma: a nuclear receptor with affinity for cannabinoids, Life Sci, 77, 1674, 10.1016/j.lfs.2005.05.039 · DOI
  37. Su, 1999, A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response, J Clin Invest, 104, 383, 10.1172/JCI7145 · DOI · Paper page
  38. Takagi, 2002, Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade, Redox Rep, 7, 283, 10.1179/135100002125000802 · DOI
  39. Sánchez-Hidalgo, 2007, Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats, Eur J Pharmacol, 562, 247, 10.1016/j.ejphar.2007.01.047 · DOI
  40. Fernandes, 2003, Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw, Br J Pharmacol, 139, 973, 10.1038/sj.bjp.0705314 · DOI
  41. Passos, 2004, Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx, J Immunol, 172, 1839, 10.4049/jimmunol.172.3.1839 · DOI
  42. Kanokmedhakul, 2007, Bioactive constituents of the roots of Polyalthia cerasoides, J Nat Prod, 70, 1536, 10.1021/np070293a · DOI
  43. Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114 · DOI · Paper page
  44. Cho, 2007, Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene, Life Sci, 80, 932, 10.1016/j.lfs.2006.11.038 · DOI
  45. Ohkawara, 2002, Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice, Gastroenterology, 123, 256, 10.1053/gast.2002.34236 · DOI
  46. Kanai, 2001, Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease, Gastroenterology, 121, 875, 10.1053/gast.2001.28021 · DOI
  47. Qualls, 2006, Suppression of experimental colitis by intestinal mononuclear phagocytes, J Leukoc Biol, 80, 802, 10.1189/jlb.1205734 · DOI
  48. Vetuschi, 2002, Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats, Dig Dis Sci, 47, 1447, 10.1023/A:1015931128583 · DOI
  49. Oshima, 2008, Changes in the expression of claudins in active ulcerative colitis, J Gastroenterol Hepatol, 23, S146, 10.1111/j.1440-1746.2008.05405.x · DOI
  50. Granata, 2006, Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages, Eur J Immunol, 36, 1938, 10.1002/eji.200535567 · DOI
  51. Eckmann, 2008, Opposing functions of IKKbeta during acute and chronic intestinal inflammation, Proc Natl Acad Sci USA, 105, 15058, 10.1073/pnas.0808216105 · DOI
  52. Cippitelli, 1995, Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun, J Biol Chem, 270, 12548, 10.1074/jbc.270.21.12548 · DOI
  53. Samten, 2002, Reduced expression of nuclear cyclic adenosine 5′-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen, J Immunol, 168, 3520, 10.4049/jimmunol.168.7.3520 · DOI
  54. Egger, 2000, Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency, Digestion, 62, 240, 10.1159/000007822 · DOI
  55. Yano, 2003, Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population, J Immunol, 171, 2510, 10.4049/jimmunol.171.5.2510 · DOI
  56. Duchmann, 2006, T regulatory cell suppression of colitis: the role of TGF-beta, Gut, 55, 604, 10.1136/gut.2005.083592 · DOI
  57. Correa, 2005, Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling, Br J Pharmacol, 145, 441, 10.1038/sj.bjp.0706215 · DOI
  58. Saubermann, 2002, Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis, Inflamm Bowel Dis, 8, 330, 10.1097/00054725-200209000-00004 · DOI
  59. Ramakers, 2007, The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis, J Clin Immunol, 27, 275, 10.1007/s10875-007-9074-2 · DOI
  60. Lu, 2006, Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection, J Pharmacol Exp Ther, 319, 269, 10.1124/jpet.106.108381 · DOI
  61. Tschöp, 2009, The cannabinoid receptor 2 is critical for the host response to sepsis, J Immunol, 183, 499, 10.4049/jimmunol.0900203 · DOI
  62. Tambe, 1996, Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene, Planta Med, 62, 469, 10.1055/s-2006-957942 · DOI
  63. Konstantinopoulos, 2007, NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression, Int J Colorectal Dis, 22, 57, 10.1007/s00384-006-0112-y · DOI
  64. Herring, 1999, Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes, J Pharmacol Exp Ther, 291, 1156, 10.1016/S0022-3565(24)35222-X · DOI
  65. Zhao, 2007, [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis], Zhonghua Gan Zang Bing Za Zhi, 15, 450
  66. O'Sullivan, 2007, Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors, Br J Pharmacol, 152, 576, 10.1038/sj.bjp.0707423 · DOI

Cited by

See all 224

Metadata

Authors
Bento, A. F., Marcon, R., Dutra, R. C., Claudino, R. F., Cola, M., Pereira Leite, D. F., & Calixto, J. B.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2011-03
Volume
178
Issue
3
Pages
1153-1166
ISSN
0002-9440
DOI
10.1016/j.ajpath.2010.11.052
Cited by
224
References
9
Language
en
Licence
Funders
  • National Council for Scientific and Technological Development
  • Coordination for Improvement of Higher Education
  • Foundation for Research Support-State of Santa Catarina
  • CNPq

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway. https://app.cochat.ai/papers/10.1016/j.ajpath.2010.11.052
The paper
Bento, A. F., Marcon, R., Dutra, R. C., Claudino, R. F., Cola, M., Pereira Leite, D. F., & Calixto, J. B. (2011). β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2010.11.052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.